Skip to content
Two people seated facing each other in chairs, engaged in conversation.

The Airway Files

Through expert discussion and patient perspectives, The Airway Files explores key topics across severe asthma and COPD, from disease mechanisms and exacerbations to timely intervention and holistic patient care. Bringing together clinical expertise and lived experience, the series provides practical scientific insights to support healthcare professionals caring for people living with asthma and COPD.

Many conversations. One evolving journey through severe asthma.

How can we recognise and manage severe asthma in clinical practice?

In the clinic – Understanding and managing severe asthma

Dr Hassan Burhan and Leanne-Jo Holmes share practical insights into recognising and managing severe asthma, from confirming the diagnosis and identifying uncontrolled inflammation to optimising treatment and timely specialist referral.

In memory of Dr Hassan Burhan.

Speakers
Dr Hassan Burhan – Consultant Respiratory Physician, Royal Liverpool University Hospital.
Leanne-Jo Holmes – Severe Asthma Nurse Consultant, Manchester University Foundation NHS Trust.

Disclosures
Dr Hassan Burhan received fees for advisory board meetings from AstraZeneca, GSK, Novartis and Roche; honoraria for lectures and conference attendance support from AstraZeneca, Chiesi, GSK and Sanofi Regeneron. Leanne-Jo Holmes has received speaking/honoraria/consultancy fees and conference attendance support from AstraZeneca, GSK and Sanofi; writing fees direct to her institution from TEVA and medical equipment direct to her institution from Nuvoair.

NX-GB-ASU-VID-260002 | August 2026

The Airway Files logo

Listen to the full podcast

In the clinic – Understanding and managing severe asthma
NX-GB-ASU-AUDI-260001 | August 2026

20
20

Discover more about managing severe asthma here

How can early recognition of type 2 inflammation support clinical decision-making in severe asthma?

Chronic causes – The underlying inflammatory pathophysiology of severe asthma

Join Dr Hitasha Rupani and Prof. Dominick Shaw as they explore the role of type 2 inflammation in severe asthma, how biomarkers can help assess patient risk, and why early identification matters.

Speakers
Dr Hitasha Rupani – Consultant Respiratory Physician, University Hospital Southampton.
Prof. Dominick Shaw – Professor of Respiratory Medicine, University of Leicester.

Disclosures
Dr Hitasha Rupani has received fees for speaking/advisory board meetings from AstraZeneca, GSK and Sanofi, travel fees from AstraZeneca and grant funding to institution from GSK.​ Prof. Dominick Shaw has received fees for advisory board meetings from AstraZeneca, Chiesi and GSK and travel fees from AstraZeneca.

NX-GB-ASU-VID-260003 | July 2026 

The Airway Files logo

Listen to the full podcast

Chronic causes – The underlying inflammatory pathophysiology of severe asthma
NX-GB-ASU-AUDI-260002 | July 2026

20
20

Discover more on the topics discussed in this episode:

Mucus plugging

Discover how mucus plugging contributes to the pathophysiology and clinical impact of severe asthma.

Recorded alongside The Airway Files: Chronic causes – The underlying inflammatory pathophysiology of severe asthma. This standalone discussion explores the impact of mucus plugging on severe asthma management.

NX-GB-RS-VID-260002 | August 2026

IgE testing in severe asthma

Discover how IgE testing can help inform the management of patients with severe asthma.

Recorded alongside The Airway Files: Chronic causes – The underlying inflammatory pathophysiology of severe asthma. This standalone discussion explores the role of IgE testing in severe asthma management.

NX-GB-RS-VID-260001 | August 2026

Find out more about the role of type 2 inflammation in severe asthma here

What can the patient perspective teach us about diagnosis, management and support in severe asthma?

The lived experience – Severe asthma from the patient perspective

Part 1: Living with severe asthma

Join Dr Samantha Walker, Katie Borg and Ryan Perrott as they discuss the hidden burden of living with severe asthma, the impact it can have on everyday life and why understanding the patient experience matters.

Speakers
Dr Samantha Walker – Director of Research and Innovation, Asthma + Lung UK.
Katie Borg –  Lead nurse, Oxford Special Airways Clinic.
Ryan Perrott – Patient with severe asthma.

Disclosures
Dr Samantha Walker: Asthma + Lung UK received funding from GSK in the past 12 months to support the Respiratory Champions Programme and the Task Force for Lung Health. Katie Borg received speaker fees from AstraZeneca, Chiesi and GSK, and received sponsorship for conferences from AstraZeneca and Chiesi.

GSK and Asthma + Lung UK are working together for healthier lungs. GSK has provided financial support to Asthma + Lung UK in connection with this campaign.

NX-GB-RS-VID-260010 | October 2026

Check back soon for Part 2: Improving diagnosis, treatment and support

Discover more about managing severe asthma here

Coming soon

What role do viral infections play in severe asthma, and what are the implications for clinical practice?

Stay tuned for new episodes of The Airway Files.

Abbreviations
COPD, chronic obstructive pulmonary disease; IgE, immunoglobulin E.

Conversations across the evolving COPD landscape

Coming soon: How can a single COPD exacerbation influence future outcomes?

Stay tuned for new episodes of The Airway Files.

Abbreviations
COPD, chronic obstructive pulmonary disease.

NX-GB-NA-WCNT-260001 | November 2026 (V1.0)